Jiangsu Hengrui Medicine
600276.SS
#465
Rank
S$58.27 B
Marketcap
$9.14
Share price
-1.00%
Change (1 day)
1.28%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$0.75 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are S$0.75 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$0.76 B-2.25%
2021-12-31S$0.78 B-1.99%
2020-12-31S$0.79 B58.22%
2019-12-31S$0.50 B-1.63%
2018-12-31S$0.51 B19.23%
2017-12-31S$0.43 B42.04%
2016-12-31S$0.30 B22.06%
2015-12-31S$0.24 B24.84%
2014-12-31S$0.19 B68.51%
2013-12-31S$0.11 B33.87%
2012-12-31S$88.26 M-2.53%
2011-12-31S$90.55 M10.47%
2010-12-31S$81.97 M19.46%
2009-12-31S$68.61 M42.19%
2008-12-31S$48.25 M-39.24%
2007-12-31S$79.41 M101.07%
2006-12-31S$39.49 M8.07%
2005-12-31S$36.54 M-28.03%
2004-12-31S$50.78 M-54.85%
2003-12-31S$0.11 B35.98%
2002-12-31S$82.72 M2.44%
2001-12-31S$80.75 M